title: Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
authors.forename: B
authors.initials: B
authors.lastname: Kocer
authors.forename: B
authors.initials: B
authors.lastname: Nazliel
authors.forename: M
authors.initials: M
authors.lastname: Oztas
authors.forename: H Z
authors.initials: HZ
authors.lastname: Batur
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011994:Recombinant Proteins; D012880:Skin Pigmentation / Q000187:drug effects; D014820:Vitiligo / Q000139:chemically induced*
chemical_list: D000276:Adjuvants, Immunologic; D007370:Interferon Type I; D011994:Recombinant Proteins; D016899:Interferon-beta; D000068556:Interferon beta-1a